These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7680588)

  • 1. Managing chronic hepatitis C virus infection.
    Lau JY; Davis GL
    BMJ; 1993 Feb; 306(6876):469-70. PubMed ID: 7680588
    [No Abstract]   [Full Text] [Related]  

  • 2. Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
    Tassopoulos NC; Hatzakis AE; Papatheodoridis GV; Karvountzis G; Troonen H; Lennartz L
    J Hepatol; 1994 Feb; 20(2):305-6. PubMed ID: 7516362
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme immunoassay of serum type IV collagen in anti-HCV positive chronic liver diseases.
    Matsuzaki Y; Yoshiga S; Sugitani T; Shoda J; Tanaka N; Osuga T
    Clin Chim Acta; 1993 Nov; 221(1-2):209-17. PubMed ID: 7512002
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation.
    Boillot O; Berger F; Rasolofo E; Mion F; Chevallier P; Gille D; Paliard P
    Transplant Proc; 1995 Aug; 27(4):2501. PubMed ID: 7544508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction.
    Marcellin P; Pouteau M; Benhamou JP
    J Hepatol; 1995 Mar; 22(3):364-9. PubMed ID: 7608489
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.
    Genesca J; Esteban JI; Quer J; Viladomiu LL; Gonzalez A; Esteban R; Guardia J
    Gut; 1993; 34(2 Suppl):S62-3. PubMed ID: 7686120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IFN in the treatment of chronic viral hepatitis. Efficacy and tolerance of lymphoblastoid alpha interferon in HIV-negative drug addicts and associated chronic active hepatitis C].
    Acone N; B1ll'Aquila G; Magliocca M; Nigro FS; Pacifico P; Imparato L
    Clin Ter; 1994 Nov; 145(11):369-72. PubMed ID: 7534222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis C].
    Viola LA; Fernández JL
    Acta Gastroenterol Latinoam; 1992; 22(2):133-4. PubMed ID: 1338677
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.
    Villa E; Grottola A; Trande P; Seium Y; Rebecchi AM; Dugani A; Manenti F
    Lancet; 1993 May; 341(8857):1413. PubMed ID: 7684479
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current aspects of hepatitis C].
    Henry JP; Hayard P; Hayani A; Ligny G
    Rev Med Brux; 1994; 15(4):211-5. PubMed ID: 7524123
    [No Abstract]   [Full Text] [Related]  

  • 15. [HCV-serotype and IFN response].
    Nakamura H; Kako M; Aikawa T; Mayumi M; Kanai K
    Nihon Rinsho; 1994 Jul; 52(7):1734-7. PubMed ID: 7521412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus antibody in Kuwait.
    al-Nakib B; Koshy A; Kaloui M; al-Ramahi S; al-Mufti S; Radhakrishnan S; al-Nakib W
    Vox Sang; 1992; 63(1):75-6. PubMed ID: 1384237
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic posttransfusion non-A, non-B hepatitis and autoimmune chronic active hepatitis-aspects on treatment, prognosis and relation to hepatitis C virus.
    Schvarcz R
    Scand J Infect Dis Suppl; 1991; 79():1-48. PubMed ID: 1658923
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus updated.
    Sherlock S; Dusheiko G
    Gut; 1991 Sep; 32(9):965-7. PubMed ID: 1655592
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T; Onji M; Michitaka K; Ohta Y
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis C with recombinant human interferon-alpha 2a: results of a randomized controlled clinical trial.
    Diodati G; Bonetti P; Noventa F; Casarin C; Rugge M; Scaccabarozzi S; Tagger A; Pollice L; Tremolada F; Davite C
    Hepatology; 1994 Jan; 19(1):1-5. PubMed ID: 7506223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.